Delivery Order SPE2DB22D3016-SPE2DB25FBEN7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,073.80 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which is not subject to a set-aside designation, represents a competitive award for pharmaceutical supply to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $2,597.47 to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 ml auto-injector units, with an ultimate completion date of September 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive award practices. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $1,092.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for AJOVY 225 mg/1.5 mL auto-injector units on September 9, 2025, with an ultimate completion date of September 10, 2025. AJOVY is a prescription medication used for chronic weight management. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of AJOVY (eptinezumab) 225 mg/1.5 mL auto-injector units valued at $1,187.64. This firm fixed-price delivery order, issued on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the Place of Performance located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4,554.55 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of AJOVY 225 mg/1.5 mL auto-injector units. The contract is classified as a firm fixed price delivery order with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award utilized no set-aside provisions, reflecting the competitive nature of the procurement. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $1,820.00 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of AJOVY 225 mg/1.5 ml auto-injector units. The contract, which carries no set-aside designation, represents a competitively awarded order with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 225 mg/1.5 ml AJOVY auto-inject pharmaceutical products. The contract has a potential value of $1,705.74 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and there is no set-aside designation. In addition, Amerisourcebergen Drug Corp...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,657.95, is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. The contract has a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of AJOVY 225 mg/1.5 mL syringes, with a ceiling value of $1,092.00. This competitive, firm fixed-price delivery order was awarded on September 17, 2025, with an ultimate completion date of September 18, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AJOVY is a prescription medication used primarily for the treatment of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order, valued at $1,836.55, is for the pharmaceutical product AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML. The contract has an ultimate completion date of April 8, 2024 and was awarded on April 5, 2024. There is no set-aside designation associated with this order. AmerisourceBergen Drug Corp is the prime...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEN7Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of AJOVY 225 mg/1.5 ml auto-injector units. The contract carries a ceiling value of $7,564.38 and is structured as a firm fixed-price delivery order with an ultimate completion date of August 12, 2025. This award represents a non-set-aside competitive procurement and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a prime vendor for the DLA Medical Supply Chain, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical devices to support military and veteran healthcare systems. AJOVY (semaglutin), used for weight management, falls within the company's portfolio of specialty medications delivered through this global pharmaceutical support vehicle, which serves the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 8/11/25 |